SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caribou Biosciences, Inc. - CRBU
StockNews.AI • 589 days
Low Materiality0/10
Information
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves...
Original sourceAI Summary
Pomerantz LLP investigates Caribou Biosciences for potential securities fraud. Caribou presented clinical data on CAR-T therapy, Evercore analysts downgraded stock. Stock price fell 15.52% after Evercore's downgrade and price target reduction.
Market-Moving
- Pomerantz LLP investigates Caribou Biosciences for potential securities fraud.
- Caribou presented clinical data on CAR-T therapy, Evercore analysts downgraded stock.
- Stock price fell 15.52% after Evercore's downgrade and price target reduction.
Key Facts
- Pomerantz LLP investigates Caribou Biosciences for potential securities fraud.
- Caribou presented clinical data on CAR-T therapy, Evercore analysts downgraded stock.
- Stock price fell 15.52% after Evercore's downgrade and price target reduction.